logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Covid-19 in humanitarian settings—modelling, measuring & applying lessons (MSF Scientific Days International 2022) | Collections | MSF Science Portal

Collection Content

Conference Material
|
Video

A multi-site synthesis on health and wellbeing during the Covid-19 pandemic: findings from seven countries

Croft LA
2022-06-07 • MSF Scientific Days International 2022
2022-06-07 • MSF Scientific Days International 2022
Conference Material
|
Video

Face mask acceptability and usage after mass distribution in a refugee camp during the Covid-19 pandemic: mixed-methods study

Sadique S
2022-06-07 • MSF Scientific Days International 2022
2022-06-07 • MSF Scientific Days International 2022
Conference Material
|
Video

Facilitating safe discharge through predicting disease progression in moderate Covid-19: development and validation of a prediction model in resource-limited settings

Chandna A
2022-06-07 • MSF Scientific Days International 2022
2022-06-07 • MSF Scientific Days International 2022
Conference Material
|
Video

Retrospective mortality and prevalence of SARS-CoV-2 antibodies in greater Omdurman, Sudan: a population–based cross–sectional survey

Moser W
2022-06-07 • MSF Scientific Days International 2022
2022-06-07 • MSF Scientific Days International 2022
Conference Material
|
Slide Presentation

Face mask acceptability and usage after mass distribution in a refugee camp during the Covid-19 pandemic: mixed-methods study

Sadique S, Lin YD, Walker SA, Rao B, du Cros PAK,  et al.
2022-05-10 • MSF Scientific Days International 2022
2022-05-10 • MSF Scientific Days International 2022
Conference Material
|
Slide Presentation

Facilitating safe discharge through predicting disease progression in moderate Covid-19: development and validation of a prediction model in resource-limited settings

Chandna A, PRIORITISE Study Group, Mahajan R, Gautam P, Mwandigha L,  et al.
2022-05-10 • MSF Scientific Days International 2022
2022-05-10 • MSF Scientific Days International 2022
Conference Material
|
Slide Presentation

Retrospective mortality and prevalence of SARS-CoV-2 antibodies in greater Omdurman, Sudan: population–based cross–sectional survey

Moser W, Hassan Fahal MA, Abualas E, Bedri S, Elsir MT,  et al.
2022-05-10 • MSF Scientific Days International 2022
2022-05-10 • MSF Scientific Days International 2022
Conference Material
|
Abstract

Retrospective mortality and prevalence of SARS-CoV-2 antibodies in greater Omdurman, Sudan: population–based cross–sectional survey

Moser W, Hassan Fahal MA, Abualas E, Bedri S, Elsir MT,  et al.
2022-05-09 • MSF Scientific Days International 2022
2022-05-09 • MSF Scientific Days International 2022
INTRODUCTION
In Sudan, since the first Covid-19 case was declared on 13 March 2020, 32,846 confirmed cases were recorded through 10 April 2021. Of these, 72% were registered in Khart...
Conference Material
|
Abstract

Face mask acceptability and usage after mass distribution in a refugee camp during the Covid-19 pandemic: mixed-methods study

Sadique S, Lin YD, Walker SA, Rao B, du Cros PAK,  et al.
2022-05-09 • MSF Scientific Days International 2022
2022-05-09 • MSF Scientific Days International 2022
INTRODUCTION
The crowded conditions within camps for refugees and internally displaced people create risk environments for unmitigated transmission of SARS-CoV-2. Within one such set...
Conference Material
|
Abstract

Facilitating safe discharge through predicting disease progression in moderate COVID-19: development and validation of a prediction model in resource-limited settings

Chandna A, PRIORITISE Study Group, Mahajan R, Gautam P, Mwandigha L,  et al.
2022-05-09 • MSF Scientific Days International 2022
2022-05-09 • MSF Scientific Days International 2022
INTRODUCTION
In locations where few people have received Covid-19 vaccines, health systems remain vulnerable to spikes in SARS-CoV-2 infections. Triage tools, which could include bio...
Conference Material
|
Abstract

A multi-site synthesis on health and wellbeing during the Covid-19 pandemic: findings from seven countries

Croft LA, Puig-García M, Silver C, Pearlman J, Stellmach DUS,  et al.
2022-05-09 • MSF Scientific Days International 2022
2022-05-09 • MSF Scientific Days International 2022
INTRODUCTION
Between 2020 and 2021, MSF’s social sciences team designed and supported implementation of qualitative assessments to better understand community-level outbreak response...
Conference Material
|
Slide Presentation

A multi-site synthesis on health and wellbeing during the Covid-19 pandemic: findings from seven countries

Croft LA, Puig-García M, Silver C, Pearlman J, Stellmach DUS,  et al.
2022-05-09 • MSF Scientific Days International 2022
2022-05-09 • MSF Scientific Days International 2022

See more collections

Power & communities (MSF Scientific Days International 2022)

Power & communities (MSF Scientific Days International 2022)
No description available
Yellow fever

Yellow fever
No description available
Expanding access to lifesaving new TB tools

Expanding access to lifesaving new TB tools
Many settings with a high burden of drug-resistant tuberculosis (DR-TB) lack access to advanced diagnostics and to groundbreaking new treatments. The Collection linked below spotlights work by MSF and collaborators to analyze barriers, identify gaps, and accelerate the roll-out of these tools to people whose lives hang in the balance. Several reports examine price, regulatory, and patent obstacles that persist despite considerable public investment into developing many of these tools. Other authors examine critical remaining weaknesses in care pathways—especially in screening and diagnosis, and particularly in children. Several studies describe new strategies that could be part of the solution, from a pilot program in Tajikisttan that trains family caregivers to treat children with DR-TB at home, to a person-centered care model adapted to a conflict zone in Afghanistan. Lastly, initial findings demonstrate that pregnant women—another vulnerable population—can be effectively treated for DR- and multidrug-resistant TB, improving maternal outcomes without harming neonates.
View All Collections
Covid-19 in humanitarian settings—modelling, measuring & applying lessons (MSF Scientific Days International 2022)

Covid-19 in humanitarian settings—modelling, measuring & applying lessons (MSF Scientific Days International 2022)